NewGenIvf (NIVF) Equity Average (2023 - 2025)

NewGenIvf (NIVF) posted quarterly Equity Average of $14688.1 billion for Q4 2025, little changed sequentially from $14688.1 billion in Q3 2025.

NewGenIvf (NIVF) Equity Average (2023 - 2025) Analysis & Trends

NewGenIvf has disclosed Equity Average across 2 years of filings, most recently posting $14688.1 billion for Q4 2025.

In Q4 2025, Equity Average changed N/A year-over-year to $14688.1 billion; the TTM figure through Dec 2025 stood at $14688.1 billion (changed N/A YoY), while the FY2025 annual figure was $12.8 million, up 1064.48% from the prior year.
Equity Average was little changed at $14688.1 billion in Q4 2025, from $14688.1 billion in the prior quarter.
Over the last five years, Equity Average for NIVF reached as high as $14688.1 billion in Q4 2025 and fell as low as $1.7 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Avg. (Qtr)
1	HCA Healthcare	87.94 Bn	90.32 Bn	16.26 Bn	-4.50 Bn
2	Chemed	18.08 Bn	18.07 Bn	215.76 Mn	913.70 Mn
3	Tenet Healthcare	16.59 Bn	15.76 Bn	4.41 Bn	4.52 Bn
4	Davita	15.37 Bn	16.23 Bn	1.07 Bn	-563.71 Mn
5	Encompass Health	10.07 Bn	10.70 Bn	1.34 Bn	3.26 Bn
6	Ensign	9.52 Bn	8.93 Bn	293.37 Mn	2.30 Bn
7	Universal Health Services	9.19 Bn	9.15 Bn	3.21 Bn	7.40 Bn
8	Pacs	6.96 Bn	6.72 Bn	345.96 Mn	994.48 Mn
9	Ww International	6.14 Bn	5.98 Bn	-149.29 Mn	320.53 Mn
10	NewGenIvf	25,304.95	-1.41 Mn	524,025.00	14,688.08 Bn

Download Data